A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a Strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen which kills more than 500,000 people each year.
Griffith University researchers have secured more than $2.6M in NHMRC Ideas Grants.
Using convalescent plasma, Griffith University researchers have identified how it may be possible to make a future vaccine that will provide protection against all major strains of COVID-19
Griffith University Institute for Glycomics researchers are closer to the development of a new vaccine aimed at preventing the deadly Streptococcus A (Strep A), which kills more than 500,000 people globally per year.
Due to the impact of COVID-19, the Vice Chancellor’s Research Excellence Awards will be held virtually this year on September 15.
Some of Griffith University’s most outstanding researchers have been honoured at the Institute for Glycomics Research Excellence Awards evening. Attended...
A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock...
Griffith University's Institute for Glycomics has announced its 2016 research excellence awards.
Griffith University researchers have secured $7.8 million in the latest funding allocation from the National Health and Medical Research Council.
Five Griffith University research projects have been awarded a total of $916,000 in funding by the Cancer Council Queensland and...
